Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
1607 studies found for:    Open Studies | "Genital Diseases, Male"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Recruiting Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia;   Benign Prostatic Hyperplasia (BPH);   Prostatism;   Lower Urinary Tract Symptoms (LUTS);   Prostatic Hypertrophy;   Hyperplasia;   Male Urogenital Diseases;   Genital Diseases, Male
Intervention: Device: Embozene Microspheres
4 Not yet recruiting Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Conditions: Spinal Cord Injury;   Spinal Cord Injuries;   Trauma, Nervous System;   Wounds and Injuries;   Central Nervous System Diseases;   Nervous System Diseases;   Spinal Cord Diseases;   Gonadal Disorders;   Endocrine System Diseases;   Hypogonadism;   Genital Diseases, Male
Interventions: Drug: testosterone enanthate, finasteride;   Drug: placebo
5 Not yet recruiting Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT
Conditions: Neisseria Gonorrhoeae Infection;   Chlamydia Trachomatis Infection;   Sexually Transmitted Diseases
Interventions: Device: NAAT 1 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 2 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 3 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 4 to Detect Rectal and Pharyngeal NG;   Device: NAAT 4 to Detect Rectal and Pharyngeal CT
6 Recruiting A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: Apalutamide
7 Recruiting PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: [68Ga]RM2;   Procedure: PET/CT
8 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
9 Not yet recruiting Mirabegron For Erectile Dysfunction
Conditions: Erectile Dysfunction;   Overactive Bladder;   Urinary Incontinence
Intervention: Drug: Mirabegron
10 Recruiting A Phase 1 Trial for Evaluation of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)
Condition: Prostate Cancer
Interventions: Drug: CTT1057;   Procedure: Prostatectomy
11 Not yet recruiting Lenvatinib and Capecitabine in Patients With Advanced Malignancies
Conditions: Advanced Cancer;   Malignant Neoplasm of Breast;   Malignant Neoplasms of Bone and Articular Cartilage;   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites;   Malignant Neoplasms of Independent (Primary) Multiple Sites;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs;   Malignant Neoplasms of Thyroid and Other Endocrine Glands;   Malignant Neoplasms of Urinary Tract
Interventions: Drug: Lenvatinib;   Drug: Capecitabine
12 Not yet recruiting SPCG17: Prostate Cancer Active Surveillance Trigger Trial
Condition: Prostate Cancer
Intervention: Procedure: Active surveillance
13 Not yet recruiting Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Radiotherapy to the pelvis;   Drug: Hormonal therapy (LHRH agonist and/or antiandrogens)
14 Not yet recruiting Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
Condition: Prostate Cancer Metastatic
Interventions: Drug: Apalutamide;   Drug: Abiraterone acetate;   Drug: Docetaxel;   Drug: Prednisone
15 Not yet recruiting Letrozole in Stimulated IVF Cycles
Condition: Subfertility
Intervention: Drug: Letrozole
16 Not yet recruiting Thyroid Autoimmunity and Reproductive Failure in Danish Women
Conditions: Thyroid;   Infertility;   Autoantibodies;   Autoimmunity;   Pregnancy Loss
Intervention:
17 Recruiting A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Insufficiency Patients
Conditions: Primary Ovarian Insufficiency;   Premature Ovarian Failure;   Infertility
Intervention: Biological: human amniotic epithelial cells (hAECs) transplantation
18 Recruiting Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: Endorectal Balloon;   Device: Rectal Spacer;   Radiation: Radiation therapy
19 Not yet recruiting Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
Condition: Genital Herpes Simplex Type 2
Intervention: Other: Non-interventional Study
20 Recruiting Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy
Condition: Prostatic Cancer
Interventions: Drug: MIDAZOLAM;   Drug: MEPIVACAÍNE;   Drug: FENTANILE;   Drug: KETAMINE
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years